Active Ingredient: TICAGRELOR
Proprietary Name: BRILINTA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 90MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N022433
Product Number: 001
Approval Date: Jul 20, 2011
Applicant Holder Full Name: ASTRAZENECA PHARMACEUTICALS LP
Marketing Status:
Prescription
Patent and Exclusivity Information
